Dec 2024 Articles

Articles
New Approaches to Lipoproteins for the Prevention of Cardiovascular Events
Fujino M, Di Giovanni G, Nicholls SJ
Journal:
J Atheroscler Thromb

First published: December 28, 2024 DOI: 10.5551/jat.RV22031
View
- Share
Articles
Management of dyslipidaemia in patients with comorbidities – facing the challenge Value and limitations of lipid lowering drugs in liver disease Effects/Interactions of lipid-lowering agents on/with the liver
Frühwald L, Fasching P, Dobrev D, et al.
Journal:
Eur Heart J Cardiovasc Pharmacother

First published: December 24, 2024 DOI: 10.1093/ehjcvp/pvae095
View
- Share
Articles
Emerging oral therapeutic strategies for inhibiting PCSK9
Ferri N, Marodin G
Journal:
Atheroscler Plus

First published: December 12, 2024 DOI: 10.1016/j.athplu.2024.11.003
View
- Share
Articles
Oral P2Y₁₂ inhibitor pre-treatment for percutaneous coronary intervention in non–ST-elevation acute coronary syndromes: evolving notions in ESC guidelines
Marco Roffi, Gilles Montalescot
Journal:
European Heart Journal

First published: December 4, 2024 DOI: 10.1093/eurheartj/ehae616
View
- Share